Perkins Capital Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
1,375,042
-43,286
-3% -$35.4K 0.78% 32
2026
Q1
$879K Buy
1,418,328
+20,910
+1% +$18.2K 0.82% 36
2025
Q4
$1.65M Buy
1,397,418
+563,490
+68% +$713K 1.31% 23
2025
Q3
$1.24M Sell
833,928
-41,937
-5% -$73.9K 1.1% 27
2025
Q2
$1.7M Sell
875,865
-34,750
-4% -$45.5K 1.71% 17
2025
Q1
$1.11M Buy
910,615
+2,750
+0.3% +$6.76K 1.17% 24
2024
Q4
$2.74M Buy
907,865
+682,665
+303% +$1.92M 2.43% 11
2024
Q3
$570K Buy
225,200
+20,850
+10% +$74.2K 0.53% 54
2024
Q2
$960K Sell
204,350
-5,650
-3% -$29.8K 0.9% 33
2024
Q1
$1.19M Sell
210,000
-250
-0.1% -$1.65K 0.99% 36
2023
Q4
$1.39M Buy
210,250
+19,750
+10% +$114K 1.19% 26
2023
Q3
$1.52M Hold
190,500
1.51% 21
2023
Q2
$1.93M Buy
190,500
+24,000
+14% +$245K 1.68% 20
2023
Q1
$1.77M Sell
166,500
-6,750
-4% -$74.5K 1.67% 19
2022
Q4
$1.99M Sell
173,250
-500
-0.3% -$4.48K 2.1% 14
2022
Q3
$1.48M Buy
+173,750
New +$1.44M 1.66% 24
2021
Q1
Sell
-11,000
Closed -$165K 108
2020
Q4
$165K Buy
+11,000
New +$179K 0.11% 88
2020
Q1
$78K Hold
10,000
0.09% 87
2019
Q4
$130K Buy
+10,000
New +$122K 0.12% 96

Other funds holding TELA

Perkins Capital Management's TELA Position: Q2 2026 in Review

Perkins Capital Management reduced its TELA Bio (TELA) stake by 3.1% in Q2 2026, selling an estimated $35.4K and leaving 1,375,042 shares worth $1.03M. The position accounts for 0.78% of the portfolio, ranked #32.

Perkins Capital Management first reported a position in TELA in Q4 2019 and has held it in 19 quarters since. The position peaked at $2.74M in Q4 2024. 15 funds tracked by Wall St. Rank hold TELA as of Q2 2026.

  • Perkins Capital Management held 1,375,042 shares of TELA Bio worth $1.03M as of Q2 2026.
  • Perkins Capital Management sold 43,286 TELA Bio shares in Q2 2026, an estimated $35.4K.
  • TELA Bio made up 0.78% of Perkins Capital Management's portfolio in Q2 2026, its #32 holding.
  • Perkins Capital Management first reported a position in TELA Bio in Q4 2019 and has held it in 19 quarters since.
  • Perkins Capital Management's TELA Bio position peaked at $2.74M in Q4 2024.
  • 15 funds tracked by Wall St. Rank held TELA Bio as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.